THE DOSAGE REGIMEN OF LEVAMISOLE IN CANCER - IS IT RELATED TO EFFICACY AND SAFETY

被引：22

作者：

AMERY, WK ^{[1
]}

BUTTERWORTH, BS ^{[1
]}

机构：

[1] JANSSEN PHARMACEUT LTD,MARLOW,BUCKS,ENGLAND

来源：

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1983年 / 5卷 / 01期

关键词：

D O I：

10.1016/0192-0561(83)90065-6

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1 / 9

页数：9

共 61 条

[1] LEVAMISOLE AND IMMUNOTHERAPY - SOME THEORETIC AND PRACTICAL CONSIDERATIONS AND THEIR RELEVANCE TO HUMAN-DISEASE
AMERY, WK
GOUGH, DA
[J]. ONCOLOGY, 1981, 38 (03) : 168 - 181
[2] AMERY WK, 1982, IMMUNOTHERAPY HUMAN, P123
[3] CLOZAPINE-INDUCED AGRANULOCYTOSIS - SITUATION REPORT UP TO AUGUST 1976
ANDERMAN, B
GRIFFITH, RW
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (03) : 199 - 201
[4] ANGELAKIS P, 1979, NOSOKOMIAKA CHRON, V41, P266
[5] LEVAMISOLE AND SURGERY IN BRONCHIAL-CARCINOMA PATIENTS - INCREASE IN DEATHS FROM CARDIORESPIRATORY FAILURE
ANTHONY, HM
MEARNS, AJ
MASON, MK
SCOTT, DG
MOGHISSI, K
DEVERALL, PB
ROZYCKI, ZJ
WATSON, DA
[J]. THORAX, 1979, 34 (01) : 4 - 12
[6] ADJUVANT CHEMOTHERAPY AND IMMUNOTHERAPY FOR COLORECTAL-CANCER - PRELIMINARY COMMUNICATION
BANCEWICZ, J
CALMAN, KC
MACPHERSON, SG
MCARDLE, CS
MCVIE, JG
SOUKOP, M
[J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1980, 73 (03) : 197 - 199
[7] BEDIKIAN AY, 1978, CANCER, V42, P2169, DOI 10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO
[8] 2-V
[9] BORDEN EC, 1982, IMMUNOTHERAPY HUMAN, P231
[10] BRINCKER H, 1980, LANCET, V2, P824